The presence of the phytochemical constituents has been reported from species of the Linderniaceae family. Objectives: The present study was designed to determine the bioactive compounds in the whole plant extracts of Bonnaya ciliata (Colsm.) Spreng. and Torenia crustacea (L.) Cham. and Schltdl. Materials and Methods: Phytochemical screening of these plants revealed the presence of several bioactive components. Liquid Chromatography Mass Spectrometry (LCMS) analysis of the ethanolic extracts was performed using LCMS equipment. Results: The phytochemical tests revealed the presence of several bioactive compounds. Utilizing qualitative analysis alongside advanced LC-MS profiling, we aimed to uncover the range of bioactive compounds these species contain. Our qualitative assessments revealed a rich array of secondary metabolites, including phenolic compounds, flavonoids, and glycosides, indicating significant bioactive potential. The LC-MS analysis further identified key constituents such as Aloesin, Luteolin-7-glucoside, Rhodioloside, and Kaempferol-3-O-glucoside, which are known for their antioxidant, anti-inflammatory, and antimicrobial properties. These findings highlight the therapeutic significance of Bonnaya ciliata (Colsm.) Spreng. and Torenia crustacea (L.) Cham. and Schltdl, suggesting their potential as sources of natural remedies. Conclusion: The findings suggest that by combining qualitative and quantitative approaches, this research provides a foundation for future studies aimed at developing plant-based solutions for health and wellness.
